The problem isn't that tirzepatide causes sagging skin directly
Plain Language Summary Obesity, a condition of higher than normal body fat, is common among adults
References: Cani PD et al., 2019 Written by Ali Rza Akn Microbiome Scientist, Author & Founder of Next-Microbiome Ali Rza Akn is a microbiome scientist with nearly 30 years of experience in translational biotechnology, systems biology, and applied microbiome research, spanning discovery, preclinical development, and clinical-stage translation
Tirzepatide offers dual agonist activity, targeting both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, which may contribute to its enhanced weight loss efficacy compared to single-receptor agonists
How to increase GLP-1 naturally While there are clearly benefits to taking GLP-1 medications and drugs, many people prefer to go with more natural methods to support and improve their health
Managing semaglutide-induced fatigue: A holistic approach To minimize side effects like fatigue, its important to increase the dose gradually under the guidance of a healthcare provider so your body can build up tolerance and reduce discomfort